Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Long-Term Debt Issuances (2022)

Cue Biopharma's Long-Term Debt Issuances history spans 1 years, with the latest figure at -$5.3 million for Q4 2022.

  • For Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to -$5.3 million; the TTM value through Sep 2023 reached -$5.3 million, down 153.0%, while the annual FY2024 figure was $18000.0, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q4 2022 was -$5.3 million at Cue Biopharma, down from $10.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $10.0 million in Q1 2022 and bottomed at -$5.3 million in Q4 2022.